SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vestor who wrote (1093)4/8/1999 12:37:00 PM
From: Doug Bean  Read Replies (1) of 1837
 
Vestor i will try to find out when national ad campaign will begin. Margin on the first bunch will be huge as it will be from the original bunch made and then written off when it was turned down the first time. It should have a good margin becasue they were going to be able to undersell Premarin by quite a bit when they were tryiing to compete as a generic. No reason to think that they will have any higher costs now ( other than the amount being paid to Cardinal). I agree that once it starts it should be a steady pull upwards. The medical group here on the thread will let us know what the acceptance will be. If they start moving prescriptions out and reordering.. we will be over the bridge and on our way home :-)) CRDoug
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News